Johnson & Johnson Announces Updated Financials and 2023 Guid

Company expects increased 2023 Reported Sales Growth of 7.0% - 8.0%, Operational Sales Growth of 7.5% - 8.5%, and Adjusted Operational Sales Growth of 6.2% - 7.2%; Figures exclude the COVID-19...

Related Keywords

Joaquin Duato , Kenvue Inc , Johnson Consumer Health , Johnson , Abiomed , Consumer Health , Consumer Health Company , Company Consumer Health , Exchange Commission , Chief Executive , Shares Outstanding , Euro Average Rate , Average Shares Outstanding , Adjusted Diluted , Private Securities Litigation Reform Act , New Consumer Health Company , Annual Report , Note Regarding Forward Looking , Quarterly Reports , Consolidated Statement , Millions Except Per Share Figures , Discontinued Operations , Basic Shares , Millions Except Per Share Data , Continuing Operations , Asset Amortization , Net Earnings , Before Tax , Income Before Tax , Quarter July , Quarter Jan , Months Jan , Markets ,